133 related articles for article (PubMed ID: 35951089)
1. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma.
Liao G; Zhang M; Wang C
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3485-3494. PubMed ID: 35951089
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma.
Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q
Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205
[TBL] [Abstract][Full Text] [Related]
3. TMED3 stabilizes SMAD2 by counteracting NEDD4-mediated ubiquitination to promote ovarian cancer.
Chen X; Zhang W; Han X; Li X; Xia L; Wu Y; Zhou Y
Mol Carcinog; 2024 May; 63(5):803-816. PubMed ID: 38411267
[TBL] [Abstract][Full Text] [Related]
4. Trafficking protein TMED3 promotes esophageal squamous cell carcinoma.
Yang Y; Liu S; Xie C; Li Q; Gao T; Liu M; Xi M; Zhao L
Biomed J; 2023 Apr; 46(2):100528. PubMed ID: 35358714
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma.
Peng Y; Liu H; Wu Q; Wang L; Yu Y; Yin F; Feng C; Ren X; Liu T; Chen L; Zhu H
BMC Cancer; 2023 Jun; 23(1):596. PubMed ID: 37380984
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma.
Wang G; Yang X; Qi M; Li M; Dong M; Xu R; Zhang C
Sci Rep; 2023 Feb; 13(1):3023. PubMed ID: 36810892
[TBL] [Abstract][Full Text] [Related]
7. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
Front Immunol; 2021; 12():628966. PubMed ID: 33664747
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the role of QPCTL in glioma progression and cancer immunotherapy.
Liu Y; Lu S; Sun Y; Wang F; Yu S; Chen X; Wu LL; Yang H; Shi Y; Zhao K
Front Immunol; 2023; 14():1166377. PubMed ID: 37063864
[TBL] [Abstract][Full Text] [Related]
9. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
11. MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3.
Peng C; Huang K; Liu G; Li Y; Yu C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1711-1719. PubMed ID: 30843262
[TBL] [Abstract][Full Text] [Related]
12. Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis.
Yang C; Wang M; Huang R; Ou L; Li M; Wu W; Lei R
Clin Breast Cancer; 2023 Apr; 23(3):291-301. PubMed ID: 36764873
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
[TBL] [Abstract][Full Text] [Related]
14. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
15. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma.
Chen J; Chen S; Li B; Zhou S; Lin H
Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280
[TBL] [Abstract][Full Text] [Related]
16. Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment.
Liu Z; Tang C; Teng X; Mohamed ZA; Fan J
J Clin Lab Anal; 2023 Apr; 37(8):e24892. PubMed ID: 37161605
[TBL] [Abstract][Full Text] [Related]
17. The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.
Wang Z; Liu Y; Mo Y; Zhang H; Dai Z; Zhang X; Ye W; Cao H; Liu Z; Cheng Q
Front Immunol; 2021; 12():731751. PubMed ID: 34603309
[TBL] [Abstract][Full Text] [Related]
18. TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma.
Li Y; Li J; Chen H; Lu B; Lu F; Chen H; Liu H; Qian C
Gene; 2023 Oct; 883():147667. PubMed ID: 37506986
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.
Wang C; Chen Q; Li S; Li S; Zhao Z; Gao H; Wang X; Li B; Zhang W; Yuan Y; Ming L; He H; Tao B; Zhong J
Oncotarget; 2017 Feb; 8(6):10287-10297. PubMed ID: 28055966
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma.
Kang K; Xie F; Wu Y; Wang Z; Wang L; Long J; Lian X; Zhang F
Int Immunopharmacol; 2021 Jul; 96():107610. PubMed ID: 33848908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
